Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-039015
Filing Date
2025-03-13
Accepted
2025-03-13 19:24:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 21456
2 EX-99.A ck0001669811-ex99_a.pdf EX-99.A 9789
  Complete submission text file 0000950170-25-039015.txt   36661
Mailing Address 4040 CAMPBELL AVE, SUITE 100 MENLO PARK CA 94025
Business Address 4040 CAMPBELL AVE, SUITE 100 MENLO PARK CA 94025 (415) 889-0550
Sight Sciences, Inc. (Subject) CIK: 0001531177 (see all company filings)

EIN.: 800625749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-92715 | Film No.: 25737291
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O SIGHT SCIENCES, INC. 4040 CAMPBELL AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address
Encrantz Staffan (Filed by) CIK: 0001870875 (see all company filings)

Type: SCHEDULE 13D/A